{"ticker": "BRVE", "overview": {"cik": "2131524", "ticker": "BRVE", "name": "Braveheart Bio, Inc.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "4", "date": "2026-08-10", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-093140", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "Insider transaction", "accession": "0001193125-26-340528", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000804", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000803", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000802", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000801", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000800", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000799", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000798", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000797", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000796", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-07", "title": "Material event", "accession": "0001628280-26-054842", "price_sensitive": true}, {"form": "S-8", "date": "2026-08-06", "title": "Employee share plan", "accession": "0001628280-26-054371", "price_sensitive": false}, {"form": "424B4", "date": "2026-08-06", "title": "S-1/A", "accession": "0001628280-26-054354", "price_sensitive": false}, {"form": "CERT", "date": "2026-08-06", "title": "Form CERT", "accession": "0001354457-26-000761", "price_sensitive": false}, {"form": "3", "date": "2026-08-06", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-091481", "price_sensitive": false}, {"form": "EFFECT", "date": "2026-08-05", "title": "Form EFFECT", "accession": "9999999995-26-002550", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "Initial insider holdings", "accession": "0000947871-26-000749", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "Initial insider holdings", "accession": "0001231919-26-000833", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "Initial insider holdings", "accession": "0001193125-26-336143", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000780", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000779", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000778", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000777", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000776", "price_sensitive": false}]}, "description": "Braveheart Bio, Inc. trades as BRVE and is registered in the United States, classified under Pharmaceutical Preparations (SIC 2834). Privy Trades holds 18 insider filings for the company, in August 2026. Across those, 10 insiders disclosed 10 open-market purchases totalling $159.03M. The most recent filing on record is dated 10 September 2026.", "exchange": null, "stats": {"buy_n": 10, "buy_sum": 159034950.0, "sell_n": 0, "sell_sum": 0, "net": 159034950.0, "insiders": 10, "first_date": "2026-08-07", "last_date": "2026-08-07"}, "metrics": {"ticker": "BRVE", "has_prices": true, "as_of": "2026-08-10", "last": 27.53, "prev_close": 30.0, "change": -2.469999999999999, "change_pct": -0.0823333333333333, "session_volume": 415791.0, "vwap_5": 29.60573959097476, "vwap_20": 29.60573959097476, "vwap_60": 29.60573959097476, "vwap_250": 29.60573959097476, "high_52w": 30.0, "low_52w": 27.53, "avg_volume_20": 1424981.3333333333, "sessions": 3, "market_cap": null}, "trades": [{"id": "13DG-0000947871-26-000860", "src": "13DG", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Braveheart Bio, Inc.", "who_key": "Braveheart Bio, Inc.", "role": "Substantial holder \u00b7 13D/A", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Braveheart Bio, Inc. moves to a 13.5% activist stake in BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/0000947871-26-000860-index.htm", "trade_date": "2026-09-10", "timestamp": "2026-09-08", "mins": 80152}, {"id": "13DG-0000947871-26-000814", "src": "13DG", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Braveheart Bio, Inc.", "who_key": "Braveheart Bio, Inc.", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Braveheart Bio, Inc. takes a 17.2% activist stake in BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/0000947871-26-000814-index.htm", "trade_date": "2026-08-18", "timestamp": "2026-08-18", "mins": 110392}, {"id": "13DG-0001889476-26-000004", "src": "13DG", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "AH Bio Fund IV, L.P.", "who_key": "AH Bio Fund IV, L.P.", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "AH Bio Fund IV, L.P. takes a 11.4% activist stake in BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/1889476/0001889476-26-000004-index.htm", "trade_date": "2026-08-14", "timestamp": "2026-08-14", "mins": 116152}, {"id": "13DG-0001231919-26-000910", "src": "13DG", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Braveheart Bio, Inc.", "who_key": "Braveheart Bio, Inc.", "role": "Substantial holder \u00b7 13G", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Braveheart Bio, Inc. takes a 5.5% passive stake in BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/0001231919-26-000910-index.htm", "trade_date": "2026-08-14", "timestamp": "2026-08-14", "mins": 116152}, {"id": "0001231919-26-000859", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "AH Bio Fund IV, L.P.", "who_key": "AH Bio Fund IV, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 19800000.0, "score": 65.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying BRVE \u2014 10 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000123191926000859/0001231919-26-000859-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0000947871-26-000783", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Erez Chimovits", "who_key": "Chimovits Erez", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 34920000.0, "score": 72.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "9 insiders pile into BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000094787126000783/0000947871-26-000783-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0000947871-26-000782", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 34920000.0, "score": 72.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "BRVE draws its 8th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000094787126000782/0000947871-26-000782-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001104659-26-093140", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.", "who_key": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "10% owner files routine paperwork on BRVE \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000110465926093140/0001104659-26-093140-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001193125-26-340528", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Forbion Growth Opportunities Fund III Cooperatief U.A.", "who_key": "Forbion Growth Opportunities Fund III Cooperatief U.A.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 64800000.0, "score": 73.2, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "7 insiders now buying BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2148132/000119312526340528/0001193125-26-340528-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000804", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "James Paul Rickey", "who_key": "Rickey James Paul", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 499986.0, "score": 55.7, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying BRVE \u2014 6 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000804/0001470831-26-000804-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000796", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "David Charles Lubner", "who_key": "Lubner David Charles", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 999990.0, "score": 51.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "5 insiders now buying BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000796/0001470831-26-000796-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000798", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Travis Murdoch", "who_key": "Murdoch Travis", "role": "CEO and President, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 1499994.0, "score": 63.6, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "4 insiders pile into BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000798/0001470831-26-000798-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000799", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Michele A. Anderson", "who_key": "Anderson Michele A.", "role": "Chief Development Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 19998.0, "score": 34.7, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 3 buying BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2141644/000147083126000799/0001470831-26-000799-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000800", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "David I. Malek", "who_key": "Malek David I", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 74988.0, "score": 37.7, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director buys $75K of BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2141639/000147083126000800/0001470831-26-000800-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000801", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Christopher Viehbacher", "who_key": "Viehbacher Christopher", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1499994.0, "score": 55.5, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "BRVE lands a $1.5M vote of confidence from A board member", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000801/0001470831-26-000801-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000803", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Tim Lohoff", "who_key": "Lohoff Tim", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BRVE \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/2142007/000147083126000803/0001470831-26-000803-index.htm", "trade_date": "2026-08-05", "timestamp": "2026-08-05", "mins": 129112}, {"id": "0001470831-26-000797", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Jasper Bos", "who_key": "Bos Jasper", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BRVE \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000797/0001470831-26-000797-index.htm", "trade_date": "2026-08-05", "timestamp": "2026-08-05", "mins": 129112}, {"id": "0001470831-26-000802", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Erez Chimovits", "who_key": "Chimovits Erez", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on BRVE \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000802/0001470831-26-000802-index.htm", "trade_date": "2026-08-05", "timestamp": "2026-08-05", "mins": 129112}], "recent_buys": [{"id": "0001470831-26-000801", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Christopher Viehbacher", "who_key": "Viehbacher Christopher", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1499994.0, "score": 55.5, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "BRVE lands a $1.5M vote of confidence from A board member", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000801/0001470831-26-000801-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000800", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "David I. Malek", "who_key": "Malek David I", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 74988.0, "score": 37.7, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director buys $75K of BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2141639/000147083126000800/0001470831-26-000800-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000799", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Michele A. Anderson", "who_key": "Anderson Michele A.", "role": "Chief Development Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 19998.0, "score": 34.7, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 3 buying BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2141644/000147083126000799/0001470831-26-000799-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000798", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Travis Murdoch", "who_key": "Murdoch Travis", "role": "CEO and President, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 1499994.0, "score": 63.6, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "4 insiders pile into BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000798/0001470831-26-000798-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000796", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "David Charles Lubner", "who_key": "Lubner David Charles", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 999990.0, "score": 51.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "5 insiders now buying BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000796/0001470831-26-000796-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001470831-26-000804", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "James Paul Rickey", "who_key": "Rickey James Paul", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 499986.0, "score": 55.7, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying BRVE \u2014 6 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000804/0001470831-26-000804-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001193125-26-340528", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Forbion Growth Opportunities Fund III Cooperatief U.A.", "who_key": "Forbion Growth Opportunities Fund III Cooperatief U.A.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 64800000.0, "score": 73.2, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "7 insiders now buying BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2148132/000119312526340528/0001193125-26-340528-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0000947871-26-000782", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 34920000.0, "score": 72.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "BRVE draws its 8th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000094787126000782/0000947871-26-000782-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0000947871-26-000783", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Erez Chimovits", "who_key": "Chimovits Erez", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 34920000.0, "score": 72.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "9 insiders pile into BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000094787126000783/0000947871-26-000783-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}, {"id": "0001231919-26-000859", "src": "INSIDERS", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "AH Bio Fund IV, L.P.", "who_key": "AH Bio Fund IV, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 19800000.0, "score": 65.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying BRVE \u2014 10 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000123191926000859/0001231919-26-000859-index.htm", "trade_date": "2026-08-07", "timestamp": "2026-08-07", "mins": 126232}], "institutional": [{"id": "13DG-0000947871-26-000860", "src": "13DG", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Braveheart Bio, Inc.", "who_key": "Braveheart Bio, Inc.", "role": "Substantial holder \u00b7 13D/A", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Braveheart Bio, Inc. moves to a 13.5% activist stake in BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/0000947871-26-000860-index.htm", "trade_date": "2026-09-10", "timestamp": "2026-09-08", "mins": 80152}, {"id": "13DG-0000947871-26-000814", "src": "13DG", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Braveheart Bio, Inc.", "who_key": "Braveheart Bio, Inc.", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Braveheart Bio, Inc. takes a 17.2% activist stake in BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/0000947871-26-000814-index.htm", "trade_date": "2026-08-18", "timestamp": "2026-08-18", "mins": 110392}, {"id": "13DG-0001889476-26-000004", "src": "13DG", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "AH Bio Fund IV, L.P.", "who_key": "AH Bio Fund IV, L.P.", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "AH Bio Fund IV, L.P. takes a 11.4% activist stake in BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/1889476/0001889476-26-000004-index.htm", "trade_date": "2026-08-14", "timestamp": "2026-08-14", "mins": 116152}, {"id": "13DG-0001231919-26-000910", "src": "13DG", "ticker": "BRVE", "cik": "2131524", "company": "Braveheart Bio, Inc.", "company_raw": "Braveheart Bio, Inc.", "who": "Braveheart Bio, Inc.", "who_key": "Braveheart Bio, Inc.", "role": "Substantial holder \u00b7 13G", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Braveheart Bio, Inc. takes a 5.5% passive stake in BRVE", "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/0001231919-26-000910-index.htm", "trade_date": "2026-08-14", "timestamp": "2026-08-14", "mins": 116152}], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Forbion Growth Opportunities Fund III Cooperatief U.A.", "who_key": "Forbion Growth Opportunities Fund III Cooperatief U.A.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 64800000.0, "sold": 0, "net": 64800000.0, "trades": 1, "top_score": 73.2, "lean": "buying", "history": [{"action": "BUY", "amount": 64800000.0, "date": "2026-08-07", "score": 73.2, "source_url": "https://www.sec.gov/Archives/edgar/data/2148132/000119312526340528/0001193125-26-340528-index.htm"}], "latest": {"action": "BUY", "amount": 64800000.0, "date": "2026-08-07", "score": 73.2, "source_url": "https://www.sec.gov/Archives/edgar/data/2148132/000119312526340528/0001193125-26-340528-index.htm"}}, {"who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 34920000.0, "sold": 0, "net": 34920000.0, "trades": 1, "top_score": 72.0, "lean": "buying", "history": [{"action": "BUY", "amount": 34920000.0, "date": "2026-08-07", "score": 72.0, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000094787126000782/0000947871-26-000782-index.htm"}], "latest": {"action": "BUY", "amount": 34920000.0, "date": "2026-08-07", "score": 72.0, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000094787126000782/0000947871-26-000782-index.htm"}}, {"who": "Erez Chimovits", "who_key": "Chimovits Erez", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 34920000.0, "sold": 0, "net": 34920000.0, "trades": 1, "top_score": 72.0, "lean": "buying", "history": [{"action": "BUY", "amount": 34920000.0, "date": "2026-08-07", "score": 72.0, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000094787126000783/0000947871-26-000783-index.htm"}], "latest": {"action": "BUY", "amount": 34920000.0, "date": "2026-08-07", "score": 72.0, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000094787126000783/0000947871-26-000783-index.htm"}}, {"who": "AH Bio Fund IV, L.P.", "who_key": "AH Bio Fund IV, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 19800000.0, "sold": 0, "net": 19800000.0, "trades": 1, "top_score": 65.9, "lean": "buying", "history": [{"action": "BUY", "amount": 19800000.0, "date": "2026-08-07", "score": 65.9, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000123191926000859/0001231919-26-000859-index.htm"}], "latest": {"action": "BUY", "amount": 19800000.0, "date": "2026-08-07", "score": 65.9, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000123191926000859/0001231919-26-000859-index.htm"}}, {"who": "Christopher Viehbacher", "who_key": "Viehbacher Christopher", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 1499994.0, "sold": 0, "net": 1499994.0, "trades": 1, "top_score": 55.5, "lean": "buying", "history": [{"action": "BUY", "amount": 1499994.0, "date": "2026-08-07", "score": 55.5, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000801/0001470831-26-000801-index.htm"}], "latest": {"action": "BUY", "amount": 1499994.0, "date": "2026-08-07", "score": 55.5, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000801/0001470831-26-000801-index.htm"}}, {"who": "Travis Murdoch", "who_key": "Murdoch Travis", "role": "CEO and President, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 1499994.0, "sold": 0, "net": 1499994.0, "trades": 1, "top_score": 63.6, "lean": "buying", "history": [{"action": "BUY", "amount": 1499994.0, "date": "2026-08-07", "score": 63.6, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000798/0001470831-26-000798-index.htm"}], "latest": {"action": "BUY", "amount": 1499994.0, "date": "2026-08-07", "score": 63.6, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000798/0001470831-26-000798-index.htm"}}, {"who": "David Charles Lubner", "who_key": "Lubner David Charles", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 999990.0, "sold": 0, "net": 999990.0, "trades": 1, "top_score": 51.0, "lean": "buying", "history": [{"action": "BUY", "amount": 999990.0, "date": "2026-08-07", "score": 51.0, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000796/0001470831-26-000796-index.htm"}], "latest": {"action": "BUY", "amount": 999990.0, "date": "2026-08-07", "score": 51.0, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000796/0001470831-26-000796-index.htm"}}, {"who": "James Paul Rickey", "who_key": "Rickey James Paul", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 499986.0, "sold": 0, "net": 499986.0, "trades": 1, "top_score": 55.7, "lean": "buying", "history": [{"action": "BUY", "amount": 499986.0, "date": "2026-08-07", "score": 55.7, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000804/0001470831-26-000804-index.htm"}], "latest": {"action": "BUY", "amount": 499986.0, "date": "2026-08-07", "score": 55.7, "source_url": "https://www.sec.gov/Archives/edgar/data/2131524/000147083126000804/0001470831-26-000804-index.htm"}}], "activity": [{"date": "2026-08-07", "net": 159034950.0}], "announcements": [{"form": "4", "date": "2026-08-10", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-093140", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "Insider transaction", "accession": "0001193125-26-340528", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000804", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000803", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000802", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000801", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000800", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000799", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000798", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000797", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "FORM 4", "accession": "0001470831-26-000796", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-07", "title": "Material event", "accession": "0001628280-26-054842", "price_sensitive": true}, {"form": "S-8", "date": "2026-08-06", "title": "Employee share plan", "accession": "0001628280-26-054371", "price_sensitive": false}, {"form": "424B4", "date": "2026-08-06", "title": "S-1/A", "accession": "0001628280-26-054354", "price_sensitive": false}, {"form": "CERT", "date": "2026-08-06", "title": "Form CERT", "accession": "0001354457-26-000761", "price_sensitive": false}, {"form": "3", "date": "2026-08-06", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-091481", "price_sensitive": false}, {"form": "EFFECT", "date": "2026-08-05", "title": "Form EFFECT", "accession": "9999999995-26-002550", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "Initial insider holdings", "accession": "0000947871-26-000749", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "Initial insider holdings", "accession": "0001231919-26-000833", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "Initial insider holdings", "accession": "0001193125-26-336143", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000780", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000779", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000778", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000777", "price_sensitive": false}, {"form": "3", "date": "2026-08-05", "title": "FORM 3", "accession": "0001470831-26-000776", "price_sensitive": false}], "performance": {"ticker": "BRVE", "has_prices": true, "summary": {"n": 10, "avg": -0.08233333333333329, "win_rate": 0.0, "best": -0.0823333333333333, "worst": -0.0823333333333333, "as_of": "2026-08-10"}, "buys": [{"who": "Viehbacher Christopher", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 1499994.0, "date": "2026-08-07", "score": 55.5, "ref_price": 30.0, "return": -0.0823333333333333}, {"who": "Malek David I", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 74988.0, "date": "2026-08-07", "score": 37.7, "ref_price": 30.0, "return": -0.0823333333333333}, {"who": "Anderson Michele A.", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Development Officer", "amount": 19998.0, "date": "2026-08-07", "score": 34.7, "ref_price": 30.0, "return": -0.0823333333333333}, {"who": "Murdoch Travis", "person_type": "CEO", "person_label": "CEOs", "role": "CEO and President, Director", "amount": 1499994.0, "date": "2026-08-07", "score": 63.6, "ref_price": 30.0, "return": -0.0823333333333333}, {"who": "Lubner David Charles", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 999990.0, "date": "2026-08-07", "score": 51.0, "ref_price": 30.0, "return": -0.0823333333333333}, {"who": "Rickey James Paul", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Financial Officer", "amount": 499986.0, "date": "2026-08-07", "score": 55.7, "ref_price": 30.0, "return": -0.0823333333333333}, {"who": "Forbion Growth Opportunities Fund III Cooperatief U.A.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 64800000.0, "date": "2026-08-07", "score": 73.2, "ref_price": 30.0, "return": -0.0823333333333333}, {"who": "ORBIMED ADVISORS LLC", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 34920000.0, "date": "2026-08-07", "score": 72.0, "ref_price": 30.0, "return": -0.0823333333333333}, {"who": "Chimovits Erez", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 34920000.0, "date": "2026-08-07", "score": 72.0, "ref_price": 30.0, "return": -0.0823333333333333}, {"who": "AH Bio Fund IV, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 19800000.0, "date": "2026-08-07", "score": 65.9, "ref_price": 30.0, "return": -0.0823333333333333}]}, "price_series": [{"date": "2026-08-06", "close": 29.8, "volume": 3292187.0}, {"date": "2026-08-07", "close": 30.0, "volume": 566966.0}, {"date": "2026-08-10", "close": 27.53, "volume": 415791.0}], "refreshing": true}